E H Cooper

1.5k total citations
39 papers, 1.2k citations indexed

About

E H Cooper is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, E H Cooper has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Epidemiology and 10 papers in Molecular Biology. Recurrent topics in E H Cooper's work include Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Research Studies (7 papers) and Glycosylation and Glycoproteins Research (6 papers). E H Cooper is often cited by papers focused on Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Research Studies (7 papers) and Glycosylation and Glycoproteins Research (6 papers). E H Cooper collaborates with scholars based in United Kingdom, Denmark and Netherlands. E H Cooper's co-authors include M A Forbes, John G. Raynes, Michael McMahon, M A Chamberlain, A. Mayer, Hai Yu, R A Crockson, I. C. M. Maclennan, Yukio Yanagisawa and Heine H. Hansen and has published in prestigious journals such as The Lancet, British Journal of Cancer and Journal of Chromatography A.

In The Last Decade

E H Cooper

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E H Cooper United Kingdom 20 523 310 234 222 194 39 1.2k
N A Brophy United States 10 759 1.5× 429 1.4× 108 0.5× 134 0.6× 111 0.6× 13 1.2k
N. I. Nissen Denmark 19 373 0.7× 252 0.8× 95 0.4× 126 0.6× 157 0.8× 58 1.0k
W. P. Laird Myers United States 18 411 0.8× 203 0.7× 169 0.7× 112 0.5× 275 1.4× 36 1.0k
Eoin F. Gaffney Ireland 23 348 0.7× 377 1.2× 112 0.5× 530 2.4× 667 3.4× 81 1.7k
Patrice A. Lee United States 11 232 0.4× 443 1.4× 271 1.2× 144 0.6× 170 0.9× 17 1.1k
M A Forbes United Kingdom 15 238 0.5× 423 1.4× 119 0.5× 133 0.6× 147 0.8× 29 1.1k
Margaret Whitacre United States 20 743 1.4× 360 1.2× 337 1.4× 131 0.6× 334 1.7× 35 1.3k
Sally Self United States 20 211 0.4× 207 0.7× 114 0.5× 351 1.6× 114 0.6× 55 1.2k
Farkas Vánky Sweden 27 806 1.5× 404 1.3× 183 0.8× 252 1.1× 190 1.0× 104 2.6k
Florian Eckel Germany 22 1.0k 1.9× 323 1.0× 134 0.6× 851 3.8× 654 3.4× 50 1.9k

Countries citing papers authored by E H Cooper

Since Specialization
Citations

This map shows the geographic impact of E H Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E H Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E H Cooper more than expected).

Fields of papers citing papers by E H Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E H Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E H Cooper. The network helps show where E H Cooper may publish in the future.

Co-authorship network of co-authors of E H Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of E H Cooper. A scholar is included among the top collaborators of E H Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E H Cooper. E H Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, E H, et al.. (1994). Bone alkaline phosphatase and prostate‐specific antigen in the monitoring of prostate cancer. The Prostate. 25(5). 236–242. 22 indexed citations
2.
Hall, N. R., et al.. (1994). The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. British Journal of Cancer. 70(3). 549–553. 31 indexed citations
3.
Pujol, J-L., et al.. (1993). Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer. British Journal of Cancer. 67(6). 1423–1429. 9 indexed citations
4.
Primrose, John, et al.. (1993). The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. British Journal of Cancer. 67(5). 1132–1135. 56 indexed citations
5.
Østerlind, Kell, et al.. (1992). Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC). British Journal of Cancer. 66(3). 594–598. 17 indexed citations
6.
Cooper, E H, et al.. (1992). The prognostic value of the tumour markers CA 195 and CEA in patients with adenocarcinoma of the pancreas.. PubMed. 18(5). 508–13. 8 indexed citations
7.
Cooper, E H, et al.. (1992). Serum bone alkaline phosphatase and CA 549 in breast cancer with bone metastases. Biomedicine & Pharmacotherapy. 46(1). 31–36. 14 indexed citations
8.
Hordon, Lesley, H. A. Bird, & E H Cooper. (1991). RENAL TUBULAR DYSFUNCTION IN RHEUMATIC DISEASES. Lara D. Veeken. 30(2). 115–118. 3 indexed citations
9.
Forbes, MA, et al.. (1991). Use of mucin like cancer associated antigen (MCA) in the management of breast cancer. British Journal of Cancer. 63(6). 1000–1004. 11 indexed citations
10.
Skov, Birgit Guldhammer, et al.. (1991). Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer. British Journal of Cancer. 63(1). 151–153. 21 indexed citations
11.
Cooper, E H, MA Forbes, & Mark Taylor. (1990). An evaluation of DUPAN-2 in pancreatic cancer and gastrointestinal disease. British Journal of Cancer. 62(6). 1004–1005. 10 indexed citations
12.
Cuzick, Jack, Bianca De Stavola, E H Cooper, C. Chapman, & I. C. M. MacLennan. (1990). Long‐term prognostic value of serum β2microglobulin in myelomatosis. British Journal of Haematology. 75(4). 506–510. 45 indexed citations
13.
Cooper, E H, et al.. (1989). An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer. British Journal of Cancer. 59(5). 797–800. 21 indexed citations
14.
Jørgensen, Lone, Heine H. Hansen, & E H Cooper. (1989). Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. European Journal of Cancer and Clinical Oncology. 25(1). 123–128. 57 indexed citations
15.
Østerlind, Kell, et al.. (1988). The prognostic influence of serum neuron specific enolase in small cell lung cancer. British Journal of Cancer. 58(6). 805–807. 42 indexed citations
16.
Mayer, A., Michael McMahon, M A Chamberlain, & E H Cooper. (1984). C reactive protein: an aid to assessment and monitoring of acute pancreatitis.. Journal of Clinical Pathology. 37(2). 207–211. 108 indexed citations
17.
Raynes, John G. & E H Cooper. (1983). Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease.. Journal of Clinical Pathology. 36(7). 798–803. 74 indexed citations
18.
Yu, Hai, Yukio Yanagisawa, M A Forbes, et al.. (1983). Alpha-1-microglobulin: an indicator protein for renal tubular function.. Journal of Clinical Pathology. 36(3). 253–259. 158 indexed citations
19.
Child, J. A., et al.. (1980). Behaviour of Serum β2-Microglobulin and Acute Phase Reactant Proteins in Chronic Lymphocytic Leukaemia. Acta Haematologica. 64(2). 79–86. 30 indexed citations
20.
Cooper, E H, Robert D. Turner, Linda Steele, & J C Goligher. (1974). Blood Muramidase Activity in Colorectal Cancer. BMJ. 3(5932). 662–664. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N A Brophy Breakdown of academic impact, for papers by N. I. Nissen Breakdown of academic impact, for papers by W. P. Laird Myers Breakdown of academic impact, for papers by Eoin F. Gaffney Breakdown of academic impact, for papers by Patrice A. Lee Breakdown of academic impact, for papers by M A Forbes Breakdown of academic impact, for papers by Margaret Whitacre Breakdown of academic impact, for papers by Sally Self Breakdown of academic impact, for papers by Farkas Vánky Breakdown of academic impact, for papers by Florian Eckel
Rankless by CCL
2026